Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TCM in Chronic Childhood ITP
NCT01226524Phase 3Terminated
- Sponsor
- Hadassah Medical Organization
- Start
- Feb 2011
- Primary completion
- Aug 2014
- Modality
- HMF (Herbal Medicine Formulation)
- Countries
- 1
01
Overview
A Phase 3 trial of bazhengsan in immune thrombocytopenia (ITP), sponsored by Hadassah Medical Organization. Started Feb 2011; status: terminated.
02
Drugs
bazhengsan
03
Conditions
immune thrombocytopenia (ITP)
Beyond the preview
Go deeper on NCT01226524.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01226524.